On 1 April this year, clinical commissioning groups (CCGs) and NHS England took on the responsibility for the effective spend of around £95 billion of public money through commissioning of healthcare in England. The changes involve the creation of NHS England as an arms-length body from the Department of Health, through which the Government sets its ambitions for health outcomes via a Mandate.
Focusing on outcomes, not process targets
Consistent with the current Mandate, the NHS Outcomes Framework introduces a new language and structure based on achieving improvements in health outcomes, through which NHS performance can be judged, commissioners of healthcare in England can be held to account, and quality improvement throughout the NHS can be driven. The NHS Outcomes Framework describes five domains (see box).
Commissioners – both NHS England in its direct commissioning role and CCGs as commissioners of secondary and community care – are mandated by the Government to make improvements against the indicators in all five of the domains.
Shift in emphasis from disease specificity
Approximately 70% of all health and social care spend is now directed to the 15–20% of the population who have three or more long-term conditions (http://bit.ly/11QUYFB [accessed 13.11.13]). This has informed a more generic approach that is reflected in the NHS Outcomes Framework and has contributed to decisions for disease-specific improvement bodies, such as NHS Diabetes, to be replaced by a single improvement body for England. NHS Improving Quality is more closely aligned with the new commissioning system, and, as the single improvement body, has a more generic approach to health improvement.
Where does diabetes sit?
Within the new framework, diabetes is seen as one of a family of cardiovascular diseases, reflected in its positioning in the Cardiovascular Disease Outcomes Strategy and within the Cardiovascular Strategic Clinical Networks.
However, the greater emphasis on multi-morbidity in old age and on cardiovascular disease, while important, must not detract from the importance of providing high-quality diabetes care and empowering individuals to self-manage their diabetes effectively at all stages of life. While high consumers of health and social care resource may often have three or more long-term conditions, diabetes is often the common antecedent. We must not allow the focus on cardiovascular disease to detract from the importance of the microvasculature in diabetes, and of course many aspects of diabetes care, such as preconception care and care during pregnancy, are not usefully seen through a cardiovascular lens at all.
Diabetes is a significant contributor to premature mortality, with around 6 years of life lost for those with type 2 diabetes (Emerging Risk Factors Collaboration, 2011). Years of life lost due to type 1 diabetes, a single long-term condition prior to the onset of complications, can be as high as 20. The apparent low rates of delivery of basic care processes and low rates of attainment of all three treatment goals for HbA1c, blood pressure and cholesterol described in the National Diabetes Audit were criticised by the National Audit Office report last year. Although it was thought to relate to a diabetes-related excess of 24 000 deaths annually, we did not know how our performance compared with other countries. Murray et al (2013) have suggested that premature mortality due to diabetes is lower in the UK than in the other 18 wealthy countries in their analysis. It may be, therefore, that our diabetes care delivery systems within the primary-care setting are already contributing positively to the longer-term clinical outcomes that really matter.
Diabetes &
Primary Care
Issue:
Vol:15 | No:06
Diabetes within the NHS in England following implementation of the Health and Social Care Act 2012
On 1 April this year, clinical commissioning groups (CCGs) and NHS England took on the responsibility for the effective spend of around £95 billion of public money through commissioning of healthcare in England. The changes involve the creation of NHS England as an arms-length body from the Department of Health, through which the Government sets its ambitions for health outcomes via a Mandate.
Focusing on outcomes, not process targets
Consistent with the current Mandate, the NHS Outcomes Framework introduces a new language and structure based on achieving improvements in health outcomes, through which NHS performance can be judged, commissioners of healthcare in England can be held to account, and quality improvement throughout the NHS can be driven. The NHS Outcomes Framework describes five domains (see box).
Commissioners – both NHS England in its direct commissioning role and CCGs as commissioners of secondary and community care – are mandated by the Government to make improvements against the indicators in all five of the domains.
Shift in emphasis from disease specificity
Approximately 70% of all health and social care spend is now directed to the 15–20% of the population who have three or more long-term conditions (http://bit.ly/11QUYFB [accessed 13.11.13]). This has informed a more generic approach that is reflected in the NHS Outcomes Framework and has contributed to decisions for disease-specific improvement bodies, such as NHS Diabetes, to be replaced by a single improvement body for England. NHS Improving Quality is more closely aligned with the new commissioning system, and, as the single improvement body, has a more generic approach to health improvement.
Where does diabetes sit?
Within the new framework, diabetes is seen as one of a family of cardiovascular diseases, reflected in its positioning in the Cardiovascular Disease Outcomes Strategy and within the Cardiovascular Strategic Clinical Networks.
However, the greater emphasis on multi-morbidity in old age and on cardiovascular disease, while important, must not detract from the importance of providing high-quality diabetes care and empowering individuals to self-manage their diabetes effectively at all stages of life. While high consumers of health and social care resource may often have three or more long-term conditions, diabetes is often the common antecedent. We must not allow the focus on cardiovascular disease to detract from the importance of the microvasculature in diabetes, and of course many aspects of diabetes care, such as preconception care and care during pregnancy, are not usefully seen through a cardiovascular lens at all.
Diabetes is a significant contributor to premature mortality, with around 6 years of life lost for those with type 2 diabetes (Emerging Risk Factors Collaboration, 2011). Years of life lost due to type 1 diabetes, a single long-term condition prior to the onset of complications, can be as high as 20. The apparent low rates of delivery of basic care processes and low rates of attainment of all three treatment goals for HbA1c, blood pressure and cholesterol described in the National Diabetes Audit were criticised by the National Audit Office report last year. Although it was thought to relate to a diabetes-related excess of 24 000 deaths annually, we did not know how our performance compared with other countries. Murray et al (2013) have suggested that premature mortality due to diabetes is lower in the UK than in the other 18 wealthy countries in their analysis. It may be, therefore, that our diabetes care delivery systems within the primary-care setting are already contributing positively to the longer-term clinical outcomes that really matter.
On 1 April this year, clinical commissioning groups (CCGs) and NHS England took on the responsibility for the effective spend of around £95 billion of public money through commissioning of healthcare in England. The changes involve the creation of NHS England as an arms-length body from the Department of Health, through which the Government sets its ambitions for health outcomes via a Mandate.
Focusing on outcomes, not process targets
Consistent with the current Mandate, the NHS Outcomes Framework introduces a new language and structure based on achieving improvements in health outcomes, through which NHS performance can be judged, commissioners of healthcare in England can be held to account, and quality improvement throughout the NHS can be driven. The NHS Outcomes Framework describes five domains (see box).
Commissioners – both NHS England in its direct commissioning role and CCGs as commissioners of secondary and community care – are mandated by the Government to make improvements against the indicators in all five of the domains.
Shift in emphasis from disease specificity
Approximately 70% of all health and social care spend is now directed to the 15–20% of the population who have three or more long-term conditions (http://bit.ly/11QUYFB [accessed 13.11.13]). This has informed a more generic approach that is reflected in the NHS Outcomes Framework and has contributed to decisions for disease-specific improvement bodies, such as NHS Diabetes, to be replaced by a single improvement body for England. NHS Improving Quality is more closely aligned with the new commissioning system, and, as the single improvement body, has a more generic approach to health improvement.
Where does diabetes sit?
Within the new framework, diabetes is seen as one of a family of cardiovascular diseases, reflected in its positioning in the Cardiovascular Disease Outcomes Strategy and within the Cardiovascular Strategic Clinical Networks.
However, the greater emphasis on multi-morbidity in old age and on cardiovascular disease, while important, must not detract from the importance of providing high-quality diabetes care and empowering individuals to self-manage their diabetes effectively at all stages of life. While high consumers of health and social care resource may often have three or more long-term conditions, diabetes is often the common antecedent. We must not allow the focus on cardiovascular disease to detract from the importance of the microvasculature in diabetes, and of course many aspects of diabetes care, such as preconception care and care during pregnancy, are not usefully seen through a cardiovascular lens at all.
Diabetes is a significant contributor to premature mortality, with around 6 years of life lost for those with type 2 diabetes (Emerging Risk Factors Collaboration, 2011). Years of life lost due to type 1 diabetes, a single long-term condition prior to the onset of complications, can be as high as 20. The apparent low rates of delivery of basic care processes and low rates of attainment of all three treatment goals for HbA1c, blood pressure and cholesterol described in the National Diabetes Audit were criticised by the National Audit Office report last year. Although it was thought to relate to a diabetes-related excess of 24 000 deaths annually, we did not know how our performance compared with other countries. Murray et al (2013) have suggested that premature mortality due to diabetes is lower in the UK than in the other 18 wealthy countries in their analysis. It may be, therefore, that our diabetes care delivery systems within the primary-care setting are already contributing positively to the longer-term clinical outcomes that really matter.
Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364: 829–41
Murray C, Richards MA, Newton JN et al (2013) UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 381: 997–1020
Further reading
Department of Health (2013) Cardiovascular Disease Outcomes Strategy. Available at: http://bit.ly/1gGFtdD
Department of Health (2013) The Mandate. A mandate from the Government to the NHS Commissioning Board: April 2013 to March 2015. Available at: http://bit.ly/15YyKYH
Department of Health (2012) The NHS Outcomes Framework 2013/2014. Available at: http://bit.ly/14DfdeX
Department of Health (2012) The management of adult diabetes services in the NHS. Available at: http://bit.ly/1j3IZeY
Health and Social Care Information Centre (2012) National Diabetes Audit 2010–2011. Report 1: Care Processes and Treatment Targets. Available at: http://bit.ly/14cZstb
Diabetes Distilled: Optimising glycaemic control is still important, especially early in type 2 diabetes
Conference over coffee: Oncology, end-of-life care, psychology and insulin dilemmas
How to follow up gestational diabetes
Diabetes Distilled: Reducing dementia risk while delivering diabetes care
Editorial: The importance of getting the correct diabetes diagnosis
PCDS Committee elections (2024): Call for candidates
Conference over coffee: Diabetes and obesity within multiple long-term conditions
A global group of experts recommends a two-pronged approach to type 2 diabetes management.
2 Oct 2024
Key messages from the 14th Northern Irish conference of the PCDS.
2 Oct 2024
The crucial steps to screen for and prevent future diabetes, and cardiovascular disease, in women who develop gestational diabetes.
20 Sep 2024
Primary care has the potential to prevent up to 45% of the population attributable risk of dementia.
17 Sep 2024